-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Angiodynamics Inc annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2018 to 2022.
- Angiodynamics Inc annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$207 K, a 93.9% increase from 2021.
- Angiodynamics Inc annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$3.42 M, a 1.19% decline from 2020.
- Angiodynamics Inc annual Deferred Federal Income Tax Expense (Benefit) for 2020 was -$3.38 M, a 201% decline from 2019.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)